COMPANY PROFILE / #779
Harbinger Health
Cambridge, MAVenture Capital-Backed
OVERVIEW
Developer of an AI-enabled blood-based cancer detection platform designed to identify cancers in a pre-disease state and reduce cancer-related uncertainty for clinicians and patients. The company offers proprietary blood-based tests, AI-driven biological analysis, and advanced screening technologies, enabling underserved individuals facing healthcare disparities to access early, affordable cancer detection.
已融资290.00
最新估值520.00
员工数65
成立年份2020
公司概况
- Companies
- Harbinger Health
- Description
- Developer of an AI-enabled blood-based cancer detection platform designed to identify cancers in a pre-disease state and reduce cancer-related uncertainty for clinicians and patients. The company offers proprietary blood-based tests, AI-driven biological analysis, and advanced screening technologies, enabling underserved individuals facing healthcare disparities to access early, affordable cancer detection.
- Website
- harbinger-health.com
- HQ Location
- Cambridge, MA
- Year Founded
- 2020
- Keywords
- cancer biology, cancer detection, cancer diagnostics, cancer drug research, early cancer detection, healthcare data analytics
- Competitors
- —
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Venture Capital-Backed
融资与估值
- Total Raised
- 290.00
- First Financing Date
- 07-Dec-2021
- First Financing Size
- 50.00
- First Financing Valuation
- 82.00
- Last Financing Date
- 01-Jan-2025
- Last Financing Deal Type
- Later Stage VC
- Last Financing Size
- —
- Last Financing Valuation
- —
- Last Financing Status
- —
- Last Known Valuation
- 520.00
- Last Known Valuation Date
- 28-Sep-2023
- Last Known Valuation Deal Type
- Early Stage VC
- Valuation Estimate
- —
- Valuation Estimate Growth Rate
- 17.98%
- Active Investors
- Catalyst Housing Group, Flagship Pioneering, M&G, Modi Ventures, Partners Investment, Pictet
- # Active Investors
- —
- Acquirers
- —
团队与联系人
- Employees
- 65
- Employee Growth %
- —
- Employee History
- 2026: 65, 2025: 79, 2024: 83, 2023: 60, 2022: 33
- Primary Contact
- Stephen Hahn
- Primary Contact Title
- Special Advisor & Board Member
- Primary Contact Email
- shahn@nucleusrad.com
- Primary Contact Phone
- +1 (980) 483-3788
增长与经营
- Revenue
- —
- Revenue Growth %
- —
- Growth Rate
- -0.56%
- Growth Rate % Change
- —
- Growth Rate Percentile
- 6
- Size Multiple
- 8.13x
- Size Multiple % Change
- 0.00%
- Size Multiple Change
- 0.00x
- Size Multiple Percentile
- —
- Majestic Referring Domains
- 105
- SimilarWeb Unique Visitors
- 260
- SimilarWeb Unique Visitors Change
- —
- SimilarWeb Growth Rate
- —
- SimilarWeb Growth Rate Percentile
- —
- Success Probability Over Time – 1 Year
- 7%
- Success Probability Over Time – 3 Year
- 18%
- Success Probability Over Time – 5 Year
- 34%
记录来源：public.companies · 原始序号 #779 · 所有字段均按数据库原值展示。